Kathy Whitney

High consumption of trans fatty acids (TFA) has been linked to increased risk of heart disease, stroke and even cancer. Read More

A copy repairman who couldn’t do his job anymore and was forced to take medical leave has returned to work. A woman who couldn’t walk from her car to her desk job has enough energy to redecorate her house. A 42-year-old mother who was too sick to care for her… Read More

Two Vanderbilt University School of Medicine students are among 11 individuals nationwide to receive Sarnoff Foundation Medical Student Research Fellowship awards for 2014-2015. Read More

Diabetic nephropathy, or kidney disease caused by diabetes, is a major source of morbidity and mortality. In the United States, more than 30 percent of patients receiving either dialytic therapy or renal transplantation have end stage renal disease as a result of diabetic nephropathy. Read More

Carrie Romero of Columbia, Tennessee, is running for her life. In 1997, when she was 28, Romero was diagnosed with dilated cardiomyopathy — a heart muscle disease that puts her at risk for sudden cardiac arrest (SCA). Read More

Vanderbilt Heart and Vascular Institute (VHVI) reached a significant milestone recently with the 100th implantation of the miniaturized HeartWare HVAD Pump, a left ventricular assist device (LVAD) that supports the heart. Read More

The Vanderbilt Cardio-Oncology program has fostered a special collaborative relationship combining the expertise of cardiologists and oncologists to understand the effects of cancer therapy on the heart. This type of collaboration is now helping to define the cardiovascular health of more than 14 million cancer survivors in the United States. Read More

Vanderbilt Heart and Vascular Institute (VHVI) recently hosted a cardiovascular health screening for participants in a nonprofit organization called the Enplay Foundation, for middle and high school athletes and their adult family members. Read More

While patient care is an important part of the careers of the majority of Vanderbilt University School of Medicine graduates, some find that they can make the greatest leadership contributions in non-clinical roles. “The solid foundation that these graduates have received in the art and science of medicine allows them… Read More

Vanderbilt Heart and Vascular Institute is participating in a global clinical trial to test the safety and efficacy of the world’s smallest pacemaker. Read More

Rivka Ihejirika is a third-year medical student from Los Angeles. She is the recipient of the Cornelius Vanderbilt Scholarship and the James Edward Holloran Scholarship, established by the Class of 1980. Read More

The 2014 Greater Nashville Heart Walk will take place on Vanderbilt’s campus on Saturday, Oct. 4. Read More

Vanderbilt Stallworth Rehabilitation Hospital (VSRH) is now offering hemodialysis for its patients, eliminating the need to transport them off site for treatment. Read More

Vanderbilt employee Drew Casey, 27, was at home when he began to experience shortness of breath. Thinking it might be a panic attack, his wife, Katie, called 911, and an ambulance took Casey to the Emergency Department, where he progressed very suddenly to circulatory failure and shock. Read More

Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease. Read More

Vanderbilt University Medical Center is one of four institutions that are part of a new research network aimed at preventing heart disease and stroke, the two leading causes of death in the world. Read More

Vanderbilt investigators have demonstrated in two studies that metformin-based treatments delay the onset and progression of chronic kidney disease (CKD) compared with other treatments for diabetes. Read More

Keith Churchwell, M.D., executive director and chief medical officer of the Vanderbilt Heart and Vascular Institute, spoke at last week’s Town Hall, a quarterly gathering of Vanderbilt Heart faculty and staff. Churchwell announced that Vanderbilt Heart – Shelbyville has moved into new office space and that a… Read More

Kidney disease is the eighth most common cause of death in the United States and affects more than 20 million people, yet many people don’t know they have kidney disease because it often develops very slowly and with minimal symptoms. For this reason, kidney disease is often referred to as a silent killer. Read More

Whether it’s former classmates or perfect strangers coming together to support a great cause, there is no denying that there is strength in numbers. Read More